Condition
Mesothelioma
Estimated Enrollment: 25
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: D4200C00075|EUDRACT Number 2007-003633-16
Study First Received: January 9, 2008
Last Updated: August 29, 2016
Estimated Primary Completion Date: January 2010
Primary Outcome Measures:
Number of Participants With Disease Control.|Number of Participants With Objective Response.|Progression-free Survival (PFS)|Overall Survival (OS)
Sponsors and Collaborators:
Genzyme, a Sanofi Company|Sanofi
Website Link: https://ClinicalTrials.gov/show/NCT00597116
